These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2200731

  • 21. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM, Harrison DE, Moysey L, Smith D, Ashcroft SJ.
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [Abstract] [Full Text] [Related]

  • 22. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
    Karjalainen J, Knip M, Hyöty H, Leinikki P, Ilonen J, Käär ML, Akerblom HK.
    Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
    [Abstract] [Full Text] [Related]

  • 23. Can islet cell antibodies predict IDDM in the general population?
    Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell PA, Dunger DB, Scott RD, Bottazzo GF, Gale EA.
    Diabetes Care; 1993 Jan; 16(1):45-50. PubMed ID: 8422831
    [Abstract] [Full Text] [Related]

  • 24. Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation.
    Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard JM.
    Diabetes; 1989 Jan; 38 Suppl 1():82-4. PubMed ID: 2642861
    [Abstract] [Full Text] [Related]

  • 25. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 1999 Jan; 107(8):496-505. PubMed ID: 10612480
    [Abstract] [Full Text] [Related]

  • 26. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ.
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [Abstract] [Full Text] [Related]

  • 27. Comparison of insulin autoantibodies in diabetes-related and healthy populations by precise displacement ELISA.
    Dean BM, McNally JM, Bonifacio E, Jennings AM, Dunger DB, Gale EA, Bottazzo GF.
    Diabetes; 1989 Oct; 38(10):1275-81. PubMed ID: 2676657
    [Abstract] [Full Text] [Related]

  • 28. Immunogenetic, clinical, and demographic characterization of childhood type I diabetes in New Zealand.
    Forbes LV, Scott RS, Brown LJ, Darlow BA.
    Diabetes Care; 1995 Nov; 18(11):1428-33. PubMed ID: 8722065
    [Abstract] [Full Text] [Related]

  • 29. Islet cell antibodies in patients with autoimmune thyroid disease.
    Yamaguchi Y, Chikuba N, Ueda Y, Yamamoto H, Yamasaki H, Nakanishi T, Akazawa S, Nagataki S.
    Diabetes; 1991 Mar; 40(3):319-22. PubMed ID: 1999272
    [Abstract] [Full Text] [Related]

  • 30. Islet cell antibodies in normal French schoolchildren.
    Lévy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P.
    Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
    [Abstract] [Full Text] [Related]

  • 31. Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.
    Ongagna JC, Levy-Marchal C.
    Diabetologia; 1995 Mar; 38(3):370-5. PubMed ID: 7758886
    [Abstract] [Full Text] [Related]

  • 32. Relation between course of disease in type 1 diabetes and islet cell antibodies.
    Zamaklar M, Jotic A, Lalic N, Lalic K, Rajkovic N, Milicic T.
    Ann N Y Acad Sci; 2002 Apr; 958():251-3. PubMed ID: 12021117
    [Abstract] [Full Text] [Related]

  • 33. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [Abstract] [Full Text] [Related]

  • 34. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
    Bingley PJ, Williams AJ, Gale EA.
    Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC, Chu SX, DeAizpurua HJ, Graham M, Honeyman MC, Colman PG.
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [Abstract] [Full Text] [Related]

  • 37. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus.
    Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, Rosenbloom AL.
    Diabetes; 1980 Aug; 29(8):589-92. PubMed ID: 7002675
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [Abstract] [Full Text] [Related]

  • 40. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W.
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.